Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Justin A. Renz currently holds 409,052 shares of Karyopharm Therapeutics Inc. (KPTI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Justin A. Renz has been a net seller of KPTI stock. They have purchased $150.4K and sold $1.8M worth of shares.
Justin A. Renz's most recent insider trade was on Aug 21, 2025, when they sold 7,037 shares at $5.93 per share.
Justin A. Renz serves as Executive at Karyopharm Therapeutics Inc. (KPTI). They have executed 36 insider transactions totaling $1.9M over their tenure at the company.
Justin A. Renz holds the position of Executive at Karyopharm Therapeutics Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 12 years and currently hold a stake valued at $0.
Justin A. Renz has shown a selling trading pattern, with $150.4K in total purchases and $1.8M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Justin A. Renz was on Dec 26, 2023, when they sold $1.4M worth of ARDX shares. This transaction involved 225,000 shares at $6.36 per share.
Justin A. Renz currently owns 409,052 shares of Karyopharm Therapeutics Inc. (KPTI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Justin A. Renz's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Justin A. Renz has 36 Form 4 filings on record as an insider at Karyopharm Therapeutics Inc..
Set alerts for Justin A. Renz and 40,000+ other insiders.